[1]
Gonzalo, J. et al. 2024. Economic impact of ovarian stimulation antagonist protocol vs primed progesterone protocol in oocyte donor program: a retrospective study. European Gynecology & Obstetrics. 6, 3 (Dec. 2024). DOI:https://doi.org/10.53260/EGO.246033 .